The UK Competition and Markets Authority has begun an investigation into the proposed US$4.7 billion merger of Stryker and Wright Medical.
Announced in November 2019, the merger would have Stryker pay US$30.75 per share to acquire all of the issues and outstanding ordinary shares of Wright Medical. With outstanding convertible notes, total enterprise value is set at US$5.4 billion. At the time of the announcement, the companies expected the acquisition to close in the second half of 2020.
The UK antitrust body’s investigation follows one opened in December 2019 by the US Federal Trade Commission. The Competition and Markets Authority stated it will decide by July 15, 2020, whether it will launch a second phase of its investigation.
Kalamazoo, Michegan-based Stryker is the world’s largest orthopedic device company, with sales of US$14.89 billion in 2019. Wright Medical, based in Amsterdam, posted net sales of US$920.9 million for the same period.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI